Taurine protects against early and late skeletal muscle dysfunction secondary to ischaemia reperfusion injury

European Journal of Surgery

Volumn 166, Issue 5, 2000, Pages 375-379

  McLaughlin, Ray ^a   Bowler, Declan ^a   Kelly, Cathal J ^a   Kay, Elaine ^a   Bouchier Hayes, David ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Ischemia reperfusion; Muscle; Taurine

Indexed keywords

TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; MUSCLE CONTRACTION; MUSCLE FUNCTION; MUSCLE TWITCH; MYOPATHY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0034090043     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: 10.1080/110241500750008916     Document Type: Conference Paper

References (42)

1. Azuma J, Sawamura A, Awata N, et al. Double blind randomized crossover trial of taurine in congestive heart failure. Curr Therap Res 1983; 34: 543-557.
2. Babior BM. Oxygen dependent microbial killing by phagocytes. NEJM 1978; 298: 642-648.
3. Baez S. An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc Res 1973; 5: 384-394.
4. Bandinelli R, Franconi F, Giotti A, et al. The positive inotropic effect of taurine and calcium and the level of taurine in ventricular strips. Br J Pharmacol 1981; 67: 115-116.
5. Banks MA, Porter DW, Martin WG, Castranova V. Taurine protects against oxidant injury to rat alveolar pneumocytes. Lombardini JB, Schaffer SW, Ajuma J, eds. Taurine: nutritional value and mechanisms of action. New York, Plenum Press, 1992: 341-350.
6. Barinaga M. Forging a path to cell death. Science 1996; 273: 735-737.
7. Binion DG, West GA, Volk EE, et al. Acquired increase in leucocyte binding by intestinal microvascular endothelium in inflammatory bowel disease. Lancet 1998; 352: 1742-1746.
8. Bowler D, MC Laughlin R, Kelly CJ, et al. Recombinant human manganese superoxide dismutase attenuates early but not delayed skeletal muscle dysfunction following reperfusion injury. Eur J Vasc Endovasc Surg 1999; 18: 216-221.
9. Carden DL, Smith JK, Korthuis RJ. Neutrophil mediated microvascular dysfunction in post-ischaemic canine skeletal muscle. Role of granulocyte adherence. Circ Res 1990; 66: 7436-7444.
10. Close R, Hoh JFY. The after effects of repetitive stimulation on the isometric twitch contraction of rat fast skeletal muscle. J Physiol 1968; 197: 461-477.
11. Finnegan N, Redmond HP, Bouchier-Hayes D. Taurine attenuates recombinant interleukin-2 activated lymphocyte mediated endothelial cell injury. Cancer 1998; 82: 186-99.
12. Flaherty JT, Bertram P, Gruber JW. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation 1994; 89: 1982-1991.
13. Fukuda K, Hirai Y, Yoshida H. Free amino acid content of lymphocytes and granulocytes compared. Clin Chem 1982; 28: 1758-1761.
14. Grace PA. Ischaemia-reperfusion injury. Br J Surg 1994; 81: 637-647.
15. Gordon RE, Shaked AA, Solano DF. Taurine protects hamster bronchioles from acute NO2-induced alterations. A histologic, ultrastructural and freeze fracture study. Am J Pathol 1986; 125: 585-600.
16. Green TR, Fellman J, Pratt KL. Anti-oxidant role and subcellular location of hypertaurine and taurine in human neutrophils. Biochim Biophys Acta 1991; 1073: 91-97.
17. Gutin B, Warren R, Wickiewicz T. Does tourniquet use during anterior cruciate ligament surgery interfere with postsurgical recovery of function? A review of the literature. Arthroscopy 1991; 7: 52-56.
18. Hassain S. Respiratory muscle dysfunction in sepsis. Moll Cell Biochem 1998; 179: 125-134.
19. Hill DK. Resting tension and the form of the twitch of rat skeletal muscle at low temperature. J Physiol 1972; 221: 161-171.
20. Huxtable RJ, Sebring L. Towards a unifying theory for the actions of taurine. TIPS 1986; 86: 481-485.
21. Huxtable RJ. Physiological actions of taurine. Physiol Rev 1992; 72: 101-163.
22. Kanwar S, Hickey MJ, Kubes P. Postischemic inflammation: a role for mast cells in intestine but not in skeletal muscle. Am J Physiol 1998; 275: 212-218.
23. Lubbe A. Heat shock attenuates endothelium dependent vasodilation in skeletal muscle microcirculation. Shock 1994; 2: 179-184.
24. Lubbe A, Garrison R, Cryer H, Alsip N, Harris P. EDRF as a possible mediator of sepsis induced arteriolar dilation in skeletal muscle. Am J Physiol 1992; 262: 880-887.
25. Majno G, Palade GE. Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Biochem Cytol 1961; 11: 571-605.
26. Milei J, Ferreira R, Llesuy S, Forcada P, Covarrubias J, Boveris A. Reduction of reperfusion injury with preoperative rapid intravenous infusion of taurine during myocardial revascularization. Am Heart J 1992; 123: 339-345.
27. O'Farrell D, Chen LE, Seaber AV, Murrell GAC, Urbaniak JR. Efficacy of recombinant human manganese superoxide dismutase compared to allopurinol in protection of ischemic skeletal muscle against "no- Reflow". J Recons Microsurg 1995; 11: 207-214.
28. Parks DA, Granger DN. Contributions of ischemia and reperfusion to mucosal lesion formation. Am J Physiol 1986; 250: 749-753.
29. Perfumo F, Canepa A, Divino-Filho JC, et al. Muscle and plasma amino acids and nutritional status in kidney transplanted children. Nephrol Dial Transplant 1994; 9: 1778-1785.
30. Redmond HP, Wang J, Bouchier-Hayes D. Taurine attenuates nitric oxide and reactive oxygen-dependant hepatocyte injury. Arch Surg 1996; 131: 1280-1287.
31. Sawamura A, Azuma J, Harada H, et al. Protection by oral pretreatment with taurine against the negative inotropic effect of low calcium medium on isolated perfused chick heart. Cardiovasc Res 1983; 27: 620-626.
32. Schaffer SW, Azuma J. Myocardial physiological effects of taurine and their significance. Lombardini JB, Schaffer SW, Ajuma J, eds., Taurine: nutritional value and mechanisms of action. New York, Plenum Press, 1992: 27-35.
33. Sies H Oxidative Stress. London: Academic Press, 1985: 1-7.
34. Takenaka H, Oshiro H, Kim D, et al. Microvascular transport is associated with TNF plasma levels and protein synthesis in postischemic muscle. Am J Physiol 1998; 274: 1914-1919.
35. Taylor RG, Fowler Jr WM. Fast and slow skeletal muscles: simultaneous in vitro study. Arch Phys Med Rehabil 1976; 57: 223-227.
36. Thomas EL. Myeloperoxidase-hydrogen peroxide chloride anti-microbial system. Effect of exogenous amines on antibacterial action against Escherichia coli infection. Immunology 1979; 25: 110-115.
37. Vinton NE, Laidlaw SA, Ament ME, Kopple JD. Taurine concentrations in plasma and blood cells of patients undergoing long term parenteral nutrition. Am J Clin Nutr 1986; 44: 398-404.
38. Wang JH, Redmond HP, Watson RGW, Condron C, Bouchier-Hayes D. The beneficial effects of taurine on the prevention of human endothelial cell death. Shock 1996; 6: 331-338.
39. Wang JH, Redmond HP, Watson RGW, Condron C, Bouchier-Hayes D. Taurine protects against sodium arsenite induced human endothelial cell apoptosis. Surg Forum 1995; 46: 661-664.
40. Wang Q, Giri SN, Hyde DM, Li C. Amelioration of bleomycin induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin. Biochem Pharmacol 1991; 42: 1115-1122.
41. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-376.
42. Welbourn CRB, Goldman G, Paterson IS, Valeri CR, Shepro D, Hechtman HB. Neutrophil elastase and oxygen radicals: synergism in lung injury after hindlimb ischaemia. Am J Physiol 1991; 260: 1852-1856.